Skip to main content

Table 3 Comparison of patient outcomes with negative, not assessable or atypical cytology diagnoses and mutational profiling

From: The added value of using mutational profiling in addition to cytology in diagnosing aggressive pancreaticobiliary disease: review of clinical cases at a single center

Mutational profiling diagnosis

Patient outcome (n = 26)

Non-aggressive disease

Aggressive disease

Cytology diagnosis

Cytology diagnosis

Atypical

Negative

Indeterminate

Atypical

Negative

Indeterminate

Negative

1

7

1

1

8

0

Positive

0

0

0

7

1

0

Non-diagnostic

0

0

0

0

0

0